Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

TherapeuticsMD Company Profile (NYSE:TXMD)

Consensus Ratings for TherapeuticsMD (NYSE:TXMD) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.00 (80.18% upside)

Analysts' Ratings History for TherapeuticsMD (NYSE:TXMD)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/1/2013Stifel NicolausInitiated CoverageBuy$8.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/31/2012 forward)
Discuss TherapeuticsMD